ARKG vs VEA
ARK Genomic Revolution ETF vs Vanguard FTSE Developed Markets ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
VEA—
Vanguard FTSE Developed Markets ETF
Developed-market stocks outside the US and Canada.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | VEA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Holdings data unavailable for ARKG.
VEA top holdings
Holdings data unavailable for VEA.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About VEA
VEA (Vanguard FTSE Developed Markets ETF) is Developed-market stocks outside the US and Canada.